We can't find the internet
Attempting to reconnect
We reduce the friction in trial enrollment for both patients and researchers.
Our software uses the most modern computational techniques to successfully match patients to medical trials suitable for their biophysical profiles and personal characteristics.
Only 4-5% of adult cancer patients participate in clinical trials. Greater trial participation would result in more rapid drug development due to faster completion of trials, faster approval of effective new therapies, broader patient access, and could save millions of dollars in costs.
Barriers to success persist and participation remains poor.
Doloribus dolores nostrum quia qui natus officia quod et dolorem. Sit repellendus qui ut at blanditiis et quo et molestiae.
Clinical trials remain complex abstractions which are difficult to find, understand, and navigate for most patients. Similarly, researchers lack information from willing participants.
Clinicians face ever-increasing pressures on their time. Experts neither understand the full landscape of the available trials for conditions they treat nor have the time during most clinic visits to assess a patient for suitable trials.
Doloribus dolores nostrum quia qui natus officia quod et dolorem. Sit repellendus qui ut at blanditiis et quo et molestiae.
Doloribus dolores nostrum quia qui natus officia quod et dolorem. Sit repellendus qui ut at blanditiis et quo et molestiae.
Doloribus dolores nostrum quia qui natus officia quod et dolorem. Sit repellendus qui ut at blanditiis et quo et molestiae.
We believe the best research is enabled when patients and practitioners can find each other. Our software uses leading computational tools to pair subjects with trials appropriate to their medical and biophysical characteristics.
Read our storyA better workflow
We believe our way is better.
